Edman Kessler, Luisa
Sigfridsson, Johnny
Hatzidaki, Dora
Bergh, Jonas
Foukakis, Theodoros
Georgoulias, Vasilios
Matikas, Alexios http://orcid.org/0000-0002-4122-9624
Funding for this research was provided by:
Stockholms Läns Landsting (K 2017-4577)
Cancerfonden (CAN 2017/1043)
Article History
Received: 30 March 2020
Accepted: 29 April 2020
First Online: 7 May 2020
Compliance with ethical standards
:
: Luisa Edman Kessler, Johnny Sigfridsson, Dora Hatzidaki and Alexios Matikas have no conflicts of interest to disclose. Jonas Bergh reports that his institution (Karolinska Institutet and/or Karolinska University Hospital) has received commercial research grants from AstraZeneca, Amgen, Bayer, Roche, Merck, Pfizer and Sanofi Aventis. No personal payments. Payment from UpToDate for a chapter in breast cancer prediction paid to Asklepios Medicine HB. Theodoros Foukakis: institutional grants from Roche and Pfizer and personal fees from Novartis, Pfizer, Roche and UpToDate; Vasilis Georgoulias has received research grants and honoraria for participation in advisory boards from Amgen, Pfizer, Astra Zeneca, Roche, Sanofi-Aventis, and Novartis.
: This is a non-interventional retrospective review of patient charts, approved by the responsible ethics committees in both Sweden (decision number 2016/1303/31 and 2018/642-32) and Greece (decision number 2019/151). No animal experiments were performed.
: This is a retrospective review of patient charts. No informed consent is needed according to the responsible ethics committees in both Sweden (decision number 2016/1303/31 and 2018/642-32) and Greece (decision number 2019/151).